ERCC5 and non-small cell lung carcinoma: Our study was the first study to investigate the effect of six SNPs of XPG on the clinical outcome of advanced NSCLC treated with platinum-based chemotherapy, and our study indicated the down regulation of XPG activity leads to enhanced survival time of advanced NSCLC with platinum-based chemotherapy.